Variants in the promoter region of CYP7A1 are associated with neuromyelitis optica but not with multiple sclerosis in the Han Chinese population

Neuroscience Bulletin

Volumn 29, Issue 5, 2013, Pages 525-530

  Zhao, Gui Xian ^a,d   Liu, Ying ^a,b   Li, Zhen Xin ^a   Lv, Chuan Zhen ^a   Traboulsee, Anthony ^c   Sadovnick, A Dessa ^c   Wu, Zhi Ying ^a  

^a FUDAN UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d Shanghai Key Laboratory of Fundus Disease   (China)

Author keywords

association; Chinese; CYP7A1; multiple sclerosis; neuromyelitis optica

Indexed keywords

CHOLESTEROL 7ALPHA MONOOXYGENASE;

5' UNTRANSLATED REGION; ARTICLE; CHINESE; CONTROLLED STUDY; CYP7A1 GENE; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; CHOLESTEROL 7-ALPHA-HYDROXYLASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84885308554     PISSN: 16737067     EISSN: 19958218     Source Type: Journal    
DOI: 10.1007/s12264-013-1347-6     Document Type: Article

References (32)

1. Martin R, McFarland HF, McFarlin DE. Immunological aspects of demyelinating diseases. Annu Rev Immunol 1992, 10: 153-187.
2. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 1996, 85: 299-302.
3. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diag nostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011, 69: 292-302.
4. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000, 343: 938-952.
5. Kira J. Neuromyelitis optica and opticospinal multiple sclerosis: Mechanisms and pathogenesis. Pathophysiology 2011, 18: 69-79.
6. Argyriou AA, Makris N. Neuromyelitis optica: a distinct demyelinating disease of the central nervous system. Acta Neurol Scand 2008, 118: 209-217.
7. Sellner J, Boggild M, Clanet M, Hintzen RQ, Illes Z, Montalban X, et al. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol 2010, 17: 1019-1032.
8. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999, 53: 1107-1114.
9. Wingerchuk DM, Lucchinetti CF. Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis. Curr Opin Neurol 2007, 20: 343-350.
10. Eckstein C, Saidha S, Levy M. A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis. J Neurol 2012, 259: 801-816.
11. International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M, Spencer CC, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011, 476: 214-219.
12. Yang KL, Chen SP, Shyr MH, Lin PY. High-resolution human leukocyte antigen (HLA) haplotypes and linkage disequilibrium of HLA-B and -C and HLA-DRB1 and -DQB1 alleles in a Taiwanese population. Hum Immunol 2009, 70: 269-276.
13. Wang H, Dai Y, Qiu W, Zhong X, Wu A, Wang Y, et al. HLA-DPB 1 0501 is associated with susceptibility to antiaquaporin-4 antibodies positive neuromyelitis optica in southern Han Chinese. J Neuroimmunol 2011, 233: 181-184.
14. Matiello M, Schaefer-Klein J, Brum DG, Atkinson EJ, Kantarci OH, Weinshenker BG, et al. HLA-DRB1*1501 tagging rs3135388 polymorphism is not associated with neuromyelitis optica. Mult Scler 2010, 16: 981-984.
15. Wang H, Zhong X, Wang K, Qiu W, Li J, Dai Y, et al. Interleukin 17 gene polymorphism is associated with antiaquaporin 4 antibody-positive neuromyelitis optica in the Southern Han Chinese - a case control study. J Neurol Sci 2012, 314: 26-28.
16. Matsushita T, Matsuoka T, Isobe N, Kawano Y, Minohara M, Shi N, et al. Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders. Tissue Antigens 2009, 73: 171-176.
17. Asgari N, Nielsen C, Stenager E, Kyvik KO, Lillevang ST. HLA, PTPN22 and PD-1 associations as markers of autoimmunity in neuromyelitis optica. Mult Scler 2012, 18: 23-30.
18. Kim HJ, Park HY, Kim E, Lee KS, Kim KK, Choi BO, et al. Common CYP7A1 promoter polymorphism associated with risk of neuromyelitis optica. Neurobiol Dis 2010, 37: 349-355.
19. Russell DW, Setchell KD. Bile acid biosynthesis. Biochemistry 1992, 31: 4737-4749.
20. Couture P, Otvos JD, Cupples LA, Wilson PW, Schaefer EJ, Ordovas JM. Association of the A-204C polymorphism in the cholesterol 7alpha-hydroxylase gene with variations in plasma low density lipoprotein cholesterol levels in the Framingham Offspring Study. J Lipid Res 1999, 40: 1883-1889.
21. Hofman MK, Princen HM, Zwinderman AH, Jukema JW. Genetic variation in the rate-limiting enzyme in cholesterol catabolism (cholesterol 7alpha-hydroxylase) influences the progression of atherosclerosis and risk of new clinical events. Clin Sci (Lond) 2005, 108: 539-545.
22. Cooper AD, Chen J, Botelho-Yetkinler MJ, Cao Y, Taniguchi T, Levy-Wilson B. Characterization of hepatic-specific regulatory elements in the promoter region of the human cholesterol 7alpha-hydroxylase gene. J Biol Chem 1997, 272: 3444-3452.
23. Karam WG, Chiang JY. Polymorphisms of human cholesterol 7 alpha-hydroxylase. Biochem Biophys Res Commun 1992, 185: 588-595.
24. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005, 58: 840-846.
25. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66: 1485-1489.
26. Wu ZY, Zhao GX, Chen WJ, Wang N, Wan B, Lin MT, et al. Mutation analysis of 218 Chinese patients with Wilson disease revealed no correlation between the canine copper toxicosis gene MURR1 and Wilson disease. J Mol Med (Berl) 2006, 84: 438-442.
27. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004, 364: 2106-2112.
28. Molowa DT, Chen WS, Cimis GM, Tan CP. Transcriptional regulation of the human cholesterol 7 alpha-hydroxylase gene. Biochemistry 1992, 31: 2539-2544.
29. Dixit M, Choudhuri G, Mittal B. Association of lipoprotein receptor, receptor-associated protein, and metabolizing enzyme gene polymorphisms with gallstone disease: A casecontrol study. Hepatol Res 2006, 36: 61-69.
30. Srivastava A, Choudhuri G, Mittal B. CYP7A1 (-204 A>C; rs3808607 and -469 T>C; rs3824260) promoter polymorphisms and risk of gallbladder cancer in North Indian population. Metabolism 2010, 59: 767-773.
31. Orton SM, Morris AP, Herrera BM, Ramagopalan SV, Lincoln MR, Chao MJ, et al. Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am J Clin Nutr 2008, 88: 441-447.
32. Roy S, Freake HC, Fernandez ML. Gender and hormonal status affect the regulation of hepatic cholesterol 7alphahydroxylase activity and mRNA abundance by dietary soluble fiber in the guinea pig. Atherosclerosis 2002, 163: 29-37.